Webinar | Cracking the code on pathogen vulnerabilities
High-throughput screening strategies to uncover and exploit novel drug targets.
11th August 2PM (BST) / 3PM (CEST) / 9AM (EDT)
High-throughput screening strategies to uncover and exploit novel drug targets.
Professor Carol Munro (University of Aberdeen, Brigid Bio) and Professor Nils Johnsson (Ulm University) join us in conversation to share how they use high-throughput screening to identify novel drug targets and produce clinically viable therapeutics.
What you’ll discover:
- Unique techniques to identify critical pathogenic vulnerabilities.
- How drugs develop from in-lab understanding to therapeutic applications.
- High-throughput assay design strategies for data reliability.
The Speakers:
Professor Carol Munro
Carol is an expert in fungal pathogens and their resistance. She recently translated her research on cell wall – host protein interactions into targeted antibody therapeutics. From this she co-founded Brigid Biologics.
Professor Nils Johnsson
Nils is an expert in cell membrane protein interactions, developing the high-throughput split-ubiquitin assay for unbiased drug target identification. His work also identifies molecular interactions that could be disrupted by drugs to dysregulate cell polarity.
The Host:
Dr Abi Sparks
Abi is an amazing scientific communicator at Singer Instruments. She is an expert in both high-throughput screening, holds a PhD in anti-microbial resistance and even had a stint teaching biology in schools.